The Stanford Egg Freezing Study

January 16, 2026 updated by: Ruth Bunker Lathi, Stanford University

The Stanford Egg Freezing Study: Investigating a Low-Cost, Low-Intensity Oocyte Cryopreservation Protocol

The purpose of this study is to see if the investigators can obtain non-inferior clinical outcomes (similar numbers of oocytes) using the Cardinal protocol, a cost-conscious, low-intensity egg freezing protocol, compared to other routinely used high-intensity clinic protocols. This is a new program for Stanford's Fertility Clinic, so the investigators are assessing patient experience and cost-benefit of a low-cost, low-intensity approach that has demonstrated non-inferiority in IVF for infertility treatment, but has not been similarly evaluated in egg freezing. All enrolled participants will choose the Cardinal protocol or the routine high-intensity protocol designated by their physician. The investigators will then assess number of eggs retrieved, as well as patient satisfaction, cost, and time needed off work to complete the egg freezing cycle. The study's findings could ultimately open the door to implementation of lower-cost standardized protocols that would be more affordable and accessible to people who may otherwise not be able to pursue fertility preservation.

Study Overview

Detailed Description

The 2020-2025 strategic plan of ASRM lists equitable, affordable access to reproductive healthcare as a high-focus priority goal, with a pressing need to identify cost-effective treatments that patients shut out by finances can still afford. While there have been some efforts made to broaden access to infertility treatment with in-vitro fertilization (IVF), there are very limited efforts to do for patients desiring egg freezing as a strategy for deferred reproduction. The Stanford Egg Freezing Study is a novel clinical trial that will be assessing for non-inferiority of outcomes from a low-cost, low-intensity approach called the Cardinal Protocol, compared to the routinely used high-intensity clinic protocols. Participant enrollment will occur locally in the greater Bay Area from patients pursuing egg freezing for fertility preservation at Stanford's Fertility clinic.

To specifically review the Cardinal Protocol, this is a low-cost, low-intensity egg-freezing protocol designed to be cost-conscious and streamlined compared to all the other routine protocols used in clinic. This means medication doses are protocolized, decreasing the total number of injections and medications needed, bloodwork and ultrasounds are limited, prevention of premature ovulation is done using oral progestins, and trigger timing is standardized as opposed to timed by provider preference, resulting in a projected cost-savings of on average $5,800 ($3,700-$11,000). This protocol has been reviewed and approved by all 8 REI board-certified infertility specialists at Stanford who based on the literature and practice deem this a standard protocol that could be offered to patients interested in a lower-cost approach.

The investigators hypothesize that the Cardinal protocol compared to the other routinely used high-intensity clinic protocols, will offer non-inferior clinical outcomes for patients with respect to the number of eggs retrieved, improve overall patient satisfaction, and decrease out-of-pocket costs, as well as time required off work to complete the treatment.

Study Type

Interventional

Enrollment (Actual)

168

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Sunnyvale, California, United States, 94087
        • Stanford Fertility and Reproductive Health Services

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Ovary-bearing individuals of reproductive age 18-40, interested in pursuing OC
  • AMH > 0.3 ng/mL
  • AMH < 7 ng/mL

Exclusion Criteria:

  • AMH > 7 ng/mL or physician concern for risk of developing severe OHSS
  • History of severe OHSS
  • Severe diminished ovarian reserve (DOR) def. as AMH < 0.3 ng/mL or FSH > 15
  • BMI > 45
  • Any contraindications to ovarian stimulation or outpatient egg retrieval under anesthesia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low-Intensity Protocol
Participants choose the low-cost, low-intensity egg-freezing protocol
The low-intensity egg freezing protocol involves fewer ultrasounds, bloodwork and injections, contributing to a lower cost. Otherwise, this protocol does not differ significantly from the other routine high-intensity clinic protocols.
Other Names:
  • Cardinal Protocol
Active Comparator: High-intensity protocol
Participants choose a routine high-intensity egg-freezing protocol
The high-intensity egg freezing protocol is a routinely used clinic protocol where patients are coming for frequent ultrasounds and bloodwork, as well as more injections, contributing to a higher overall cost for egg-freezing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oocyte yield per retrieval or egg freezing cycle
Time Frame: Identified within 24 hours of the oocyte retreival
Number of oocytes retrieved
Identified within 24 hours of the oocyte retreival
Mature oocytes cryopreserved per egg freezing cycle
Time Frame: Identified within 24-48 hours of the oocyte retreival
Number of mature oocytes cryopreserved
Identified within 24-48 hours of the oocyte retreival

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant satisfaction with egg freezing experience and specific protocol (assessed using the Likert scale)
Time Frame: Identified on post-cycle survey completed 1-2 months following oocyte retrieval
Assessment of satisfaction on scale of 1-5 towards egg freezing process and protocol
Identified on post-cycle survey completed 1-2 months following oocyte retrieval
Out-of-pocket costs of the egg freezing cycle for the participant
Time Frame: Identified on post-cycle survey completed 1-2 months following oocyte retrieval and via the electronic medical record
With or without insurance coverage for egg freezing, with an assessment of total costs or charges of the cycle, including medication costs
Identified on post-cycle survey completed 1-2 months following oocyte retrieval and via the electronic medical record
Time off-work needed to complete the egg freezing cycle
Time Frame: Identified on post-cycle survey completed 1-2 months following oocyte retrieval
Not including the egg retrieval procedure day
Identified on post-cycle survey completed 1-2 months following oocyte retrieval
Additional cost per additional oocytes retrieved
Time Frame: Identified from post-cycle survey completed 1-2 months following oocyte retrieval
Cost-benefit analyses
Identified from post-cycle survey completed 1-2 months following oocyte retrieval

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ruth Lathi, MD, Stanford University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 26, 2023

Primary Completion (Actual)

January 31, 2025

Study Completion (Actual)

April 4, 2025

Study Registration Dates

First Submitted

April 6, 2023

First Submitted That Met QC Criteria

April 23, 2023

First Posted (Actual)

May 3, 2023

Study Record Updates

Last Update Posted (Actual)

January 20, 2026

Last Update Submitted That Met QC Criteria

January 16, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fertility Issues

Clinical Trials on Low-Intensity Egg Freezing Protocol

Subscribe